A double-masked, placebo-controlled, randomized study was done to assess the safety and clnical and quantitative microbiologic efficacy of 1% mercuric oxide (yellow) ophthalmic ointment in the treatment of eyelid infections, i.e., bacterial blepharitis. A total of 39 patients with bacterial counts and clnal signs indicative of eyelid infection were treated twice daily for 7 days. Clinical biomicroscopic exmination and quantitative microbiologic cultures were done just prior to initiation of treatment and again on days 3 and 7. Statistical analysis revealed a sigicant improvement in the clinical signs, bacterial count, cure rate, and improvement rate for subjec takidng the active medication, compared with those taking the placebo on days 3 and 7. In addition, the medication was well tolerated.Mercuric oxide (yellow) is an antibacterial agent which has been incorporated into an ointment base for ophthalmic use in the treatment of common minor eyelid infections. It has been available in this form without prescription for over 30 years. It is antibacterial by its ability to reversibly inhibit bacterial sulfhydryl enzymes (5). Side effects, other than minor local irritation experienced by some individuals upon initial application, are rare with short-term use. Reports of local hypersensitivity reactions resulting in reversible blepharitis and conjunctivitis have also been rare (10). Rarely, continuous long-term use has resulted in bluish gray discoloration of the eyelids, conjunctiva, and peripheral cornea, without irritation or disturbance of visual acuity (20).Bacterial blepharitis is a common minor infection of the eyelid margin and is an indication for treatment with an antibacterial agent such as mercuric oxide. The safety and efficacy of 1% mercuric oxide ophthalmic ointment in the treatment of minor eyelid infections have been addressed in one report in the literature (9). That study concluded that the medication was safe and effective in reducing the number of bacteria in subjects with blepharitis or styes. This study was designed to assess the effects of 1% yellow mercuric oxide ophthalmic ointment on clinical signs and symptoms of blepharitis as well as the safety and quantitative microbiologic efficacy of the ointment.
MATERLALS AND METHODSPreliminary study. A preliminary study was done to assess the number and type of bacteria present as normal base-line flora of the eyelid margin in this geographic area. The purpose of this study was to establish guidelines for what would be quantitatively considered microbiologically abnormal. These guidelines would improve the sensitivity of the study for detecting a treatment effect, if one existed. Any inadequacy of these guidelines would result in less of a difference in the response rate between the treatment and control groups. Cultures of the lower eyelid margin were taken from both eyes of 10 subjects who were determined by biomicroscopy to be free of eyelid infection. The culture and processing techniques are described below. From the preliminary study we deriv...